Skip to main content
KERASTONE - Healthcare Innovation Delivered

We build hospitalsengineered to endure.Clinically. Financially.Generationally.

KERASTONE develops, operates and scales private medical infrastructure where it is most needed and least built. Twenty years of hands-on operations, anchored by the LISOD flagship and a curated ecosystem of world-class partners.

20years operating3,000–4,000new patients / yearSheba · Vital · GE · Siemens

Strategic Ecosystem

Sheba Medical Center
ARC Innovation
Vital Capital
GE HealthCare
Siemens Healthineers
IBA — Ion Beam Applications
Sheba Medical Center
ARC Innovation
Vital Capital
GE HealthCare
Siemens Healthineers
IBA — Ion Beam Applications

KERASTONE Doctrine

“Private healthcare is built the way it is operated. With an owner’s mindset, long-horizon capital and a clinical model that has to work on day one.”

KERASTONE Operating Principles

Owner’s Mindset

Five operating principles.
One responsibility.

Every KERASTONE hospital is structured against these five operating principles - the discipline that turns ambitious healthcare opportunities into facilities that operate, grow and last.

01

Principle / 04

Patient First

Every clinical, operational and capital decision is judged by its impact on the patient. The patient experience governs every decision, big or small.

02

Principle / 04

Capital discipline

Every hospital is built as if our own balance sheet underwrites it. No shortcuts, no inflated assumptions.

03

Principle / 04

Long term responsibility

We commit to the operating life of the asset, not just the opening day. An owner's posture from day one.

04

Principle / 04

Operational continuity

Designed to keep clinical, financial and managerial systems running through volatility, transitions and growth.

05

Principle / 04

Structured growth

Each hospital scales on a documented operating model - capacity, talent, technology and partnerships sequenced deliberately.

The KERASTONE Approach

From concept to operation
in seven moves.

The way an institutional operator builds, opens and runs a healthcare facility. Owner-led at every stage. No two engagements look the same; the sequence does.

  1. Initial Engagement

    A confidential conversation to understand the opportunity, the market and the people behind the venture.

  2. Opportunity Review

    A first strategic review of the venture's logic, fit and long-term potential.

  3. Concept Validation

    Testing the venture concept against medical, operational and commercial reality.

  4. Business and Medical Planning

    Structuring the venture across clinical model, business model, financial logic and operations.

  5. Implementation Support

    Coordinating partners, equipment, infrastructure and clinical setup through to opening.

  6. Operations and Stabilization

    Supporting the venture through its first operating cycles toward steady-state performance.

  7. Long-Term Partnership or Structured Exit

    Continuing involvement as a long-term partner or transitioning the venture under a clear, structured plan.

Explore the full approach→
LISOD pastoral hospital campus
LISOD / Kyiv / 2007
LISOD green rural hospital exterior
LISOD landscaped medical campus path

Project / Protocol - 01

The LISOD flagship.
Twenty years of clinical operation.

LISOD, the Hospital of Israeli Oncology in Ukraine, represents KERASTONE's long-term hands-on experience in developing and operating advanced private oncology infrastructure. The center was built around a full cycle of modern oncological care, including diagnostics, treatment, surgery and rehabilitation.

LISOD also reflects the kind of long-term resilience KERASTONE brings to healthcare ventures. Operating and supporting a medical center in a complex environment requires more than planning. It requires responsibility, continuity and an owner's mindset.

2007

Opened

3,000-4,000

New patients / year

50,000+

Patients treated

Diagnostics to rehabilitation

Care cycle

View LISOD case study

Proven Impact

Two decades of operating private medical facilities in markets that demand resilience.

20+

Years operating private healthcare facilities

50K+

Patients treated at LISOD flagship

6

Active and developing markets

200+

Daily clinical capacity at flagship

4

World-class medical technology partners

2

Continents under active development

Global Footprint

A command view of emerging healthcare markets.

Active and developing healthcare facilities across Eastern Europe, CIS countries, Central Asia and West Africa - selected for clinical demand, structural opportunity and long-horizon viability.

N · 30°KERASTONE · Global OperationsActive Nodes · 6
Initialising globe…
Flagship projectActive / developing

Selected facility

Ukraine

LISOD - Hospital of Israeli Oncology

Private oncology hospital developed and operated by KERASTONE in continuous service since 2007. A full-cycle cancer center built on Israeli clinical standards, treating thousands of new patients each year and supported continuously through complex environments.

  • Ukraine, Kyiv: LISOD - Hospital of Israeli Oncology. Flagship operating project. Private oncology hospital developed and operated by KERASTONE in continuous service since 2007. A full-cycle cancer center built on Israeli clinical standards, treating thousands of new patients each year and supported continuously through complex environments.
  • Albania, Tirana: Private healthcare venture. Active or developing project. Healthcare venture under development in an emerging European market, structured around private capacity, international clinical standards and a long-horizon operating model.
  • Georgia, Tbilisi: Private healthcare venture. Active or developing project. Caucasus regional venture leveraging KERASTONE's two decades of CIS experience and its clinical partnerships with leading Israeli medical institutions.
  • Moldova, Chișinău: Private healthcare venture. Active or developing project. Private medical infrastructure in Eastern Europe focused on long-horizon investment, sustainable operations and translation of Israeli clinical know-how into the local market.
  • Côte d'Ivoire, Abidjan: Private healthcare venture. Active or developing project. Healthcare venture development in West Africa, the gateway market for KERASTONE's expansion across the African continent, in collaboration with local and international partners.
  • Uzbekistan, Tashkent: Private healthcare venture. Active or developing project. Private healthcare development in a fast-growing Central Asian market with strong demand for advanced clinical capacity and international standards of care.

Join the best

Led by KERASTONE.
Strengthened by world-class partners.

Each facility is built around a tailored ecosystem of medical institutions, innovation platforms, technology providers and strategic capital - assembled and orchestrated under KERASTONE oversight.

Sheba Medical CenterARC InnovationVital CapitalGE HealthCareSiemens HealthineersIBASheba Medical CenterARC InnovationVital CapitalGE HealthCareSiemens HealthineersIBA

Medical institution

01 / 06
Sheba Medical Center

Sheba Medical Center

Clinical excellence partner

Strategic collaboration with one of the world's leading academic medical centers, providing clinical expertise, advisory capacity and access to senior physicians across oncology, imaging, surgery and innovation.

Innovation ecosystem

02 / 06
ARC Innovation

ARC Innovation

Healthcare innovation ecosystem

Direct connection to Israel's flagship clinical innovation ecosystem - a gateway to digital health, AI in medicine, advanced imaging and emerging treatment protocols translated into venture-grade clinical practice.

Strategic capital

03 / 06
Vital Capital

Vital Capital

Strategic capital partner

Impact-driven Israeli investment partner focused on essential infrastructure across emerging markets. KERASTONE serves as Vital's healthcare arm, operating with long-horizon, owner-grade capital discipline.

Medical technology

04 / 06
GE HealthCare

GE HealthCare

Imaging and clinical technology

Long-standing relationships with leading global manufacturers for diagnostic imaging, oncology systems, monitoring and intervention technology - procured, deployed and supervised under KERASTONE oversight.

Medical technology

05 / 06
Siemens Healthineers

Siemens Healthineers

Diagnostics and advanced imaging

Access to advanced diagnostic platforms - CT, MRI, molecular imaging and laboratory diagnostics - selected, configured and integrated to match the clinical model of each venture.

Medical technology

06 / 06
IBA

IBA

Radiation therapy and PET-CT

Specialist partner for proton therapy, radiopharmaceuticals and nuclear medicine infrastructure, supporting advanced oncology programs in KERASTONE-led ventures.

Strategic inquiries

Let’s discuss your next healthcare facility.

Contact Us Directly

Replies within 2 business days